🔎 Trials Near Me

Home › NCT07717554

Effect of Virtual Yoga in Diabetic Gastroparesis Patients

Recruiting

The Effect of Virtual Yoga Intervention on Symptom Severity and Quality of Life in Patients With Diabetic Gastroparesis

Who can join

Ages 18 to 65 · All sexes

Full eligibility criteria
Inclusion Criteria:

* History of type 1 or type 2 diabetes Gastroparesis defined by documented delayed gastric emptying, assessed by a 4-hour gastric emptying test showing more than 10% retained food in the stomach after 4 hours. This test must have been performed clinically before study enrolment.
* Experiencing at least moderate Gastroparesis symptoms

Exclusion Criteria:

* Patients with severe depression or severe anxiety as assessed by screening questionnaire. Patients with Active inflammatory bowel disease. Participants with abdominal surgeries within the last 3 months. Severe Co-morbidities: Presence of severe comorbid conditions (e.g., advanced cardiovascular or respiratory disease) that could interfere with participation in the yoga intervention. Patients who self-report with current Pregnancy and Breastfeeding
* Regular yoga practitioners (more than once a week) in the last 6 months. Undergoing current treatment for any cancer.

About the study

The purpose of this study is to investigate the potential benefits of an online yoga module for patients with gastroparesis. Specifically, the study aims to:

1. Evaluate the Impact of Yoga Practices: Examine whether practicing yoga, including pranayama (breathing techniques), mindfulness meditation, and guided relaxation, can help reduce symptoms of gastroparesis, such as nausea, vomiting, bloating, and abdominal pain. 2. Assess Psychological Factors: Determine if the yoga intervention can improve associated psychological factors, including mental well-being, sleep quality, and overall quality of life for individuals with gastroparesis. 3. Provide Evidence-Based Insights: Contribute to the evidence base on the effectiveness of non-pharmacological treatments like yoga in managing gastroparesis, which may offer an additional, accessible management option for patients.

What is being tested

Sponsor: Ohio State University · Participants: 240 · Started: Jul 17, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07717554

Locations in the U.S.

OhioOhio State University Wexner Medical Center, Columbus

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.